Loading data
CELUNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 26.55 m USD | 54.22 m USD | 22.77 m USD | 17.98 m USD | 21.34 m USD |
| Cost of revenue | 20.07 m USD | 14.99 m USD | 16.02 m USD | — | — |
| Gross profit | — | — | 6.76 m USD | -1.69 m USD | 11.68 m USD |
| Research and development expense | 15.03 m USD | 17.39 m USD | 30.47 m USD | 78.36 m USD | 88.35 m USD |
| Selling, general and administrative expense | 51.27 m USD | 58.64 m USD | 50.58 m USD | 66.02 m USD | 71.34 m USD |
| Operating profit | -61.31 m USD | -38.36 m USD | -192.29 m USD | -25.6 m USD | -109.06 m USD |
| Profit before tax | -91.71 m USD | -57.89 m USD | -196.29 m USD | 14.21 m USD | -100.1 m USD |
| Income tax expense | 3 k USD | — | 10 k USD | 13 k USD | 20 k USD |
| Net income (reported basis) | -91.72 m USD | -57.89 m USD | -196.3 m USD | 14.19 m USD | -100.12 m USD |
| Net income attributable to common shareholders | -91.8 m USD | -57.89 m USD | — | — | — |
| Basic earnings per share | -3.59 USD/share | -2.64 USD/share | -11.02 USD/share | 1.01 USD/share | -1.49 USD/share |
| Diluted earnings per share | -3.59 USD/share | -2.64 USD/share | -11.02 USD/share | 0.95 USD/share | -1.49 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.